Dyslipidemia in children with chronic kidney disease—findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study
Pediatric Nephrology · 2024-09 · 39 (9) · 2759-2772
DOI: 10.1007/s00467-024-06389-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Nephrology, online erschienen am 08.05.2024. Verfasst von Francesca Mencarelli und 21 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Nephrology Unit, Department of Pediatrics, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Dyslipidemias, Renal Insufficiency, Chronic, Cardiovascular Diseases, Glomerular Filtration Rate. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Wissenschaft, Forschung und Wirtschaft, European Renal Association-European Dialysis and Transplant Association, KfH-Stiftung Präventivmedizin.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Dyslipidemia is an important and modifiable risk factor for CVD in children with CKD.
Methods
In a cross-sectional study of baseline serum lipid levels in a large prospective cohort study of children with stage 3–5 (predialysis) CKD, frequencies of abnormal lipid levels and types of dyslipidemia were analyzed in the entire cohort and in subpopulations defined by fasting status or by the presence of nephrotic range proteinuria. Associated clinical and laboratory characteristics were determined by multivariable linear regression analysis.
Results
A total of 681 patients aged 12.2 ± 3.3 years with a mean eGFR of 26.9 ± 11.6 ml/min/1.73 m 2 were included. Kidney diagnosis was classified as CAKUT in 69%, glomerulopathy in 8.4%, and other disorders in 22.6% of patients. Nephrotic range proteinuria (defined by a urinary albumin/creatinine ratio > 1.1 g/g) was present in 26.9%. Dyslipidemia was found in 71.8%, and high triglyceride (TG) levels were the most common abnormality (54.7%). Fasting status (38.9%) had no effect on dyslipidemia status. Except for a significant increase in TG in more advanced CKD, lipid levels and frequencies of dyslipidemia were not significantly different between CKD stages. Hypertriglyceridemia was associated with younger age, lower eGFR, shorter duration of CKD, higher body mass index (BMI-SDS), lower serum albumin, and higher diastolic blood pressure.
Conclusions
Dyslipidemia involving all lipid fractions, but mainly TG, is present in the majority of patients with CKD irrespective of CKD stage or fasting status and is significantly associated with other cardiovascular risk factors. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Nephrology Unit, Department of Pediatrics, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
- Clinic of Pediatrics, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- Institute for Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
- Department of Pediatric Nephrology, Cukurova University, Adana, Turkey.
- Division of Pediatric Nephrology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
- Department of Pediatric Nephrology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
ORCID-Profile: Uwe Querfeld
Förderung
- Bundesministerium für Wissenschaft, Forschung und Wirtschaft
- European Renal Association-European Dialysis and Transplant Association
- KfH-Stiftung Präventivmedizin
- Charité - Universitätsmedizin Berlin
Zitieren
APA
Mencarelli, F., Azukaitis, K., Kirchner, M., Bayazit, A., Duzova, A., Canpolat, N., Bulut, I. K., Obrycki, L., Ranchin, B., Shroff, R., Caliskan, S., Candan, C., Yilmaz, A., Özcakar, Z. B., Halpay, H., Kiyak, A., Erdogan, H., Gellermann, J., Balat, A., …, & Querfeld, U. (2024). Dyslipidemia in children with chronic kidney disease—findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study. Pediatric Nephrology, 39(9), 2759-2772. https://doi.org/10.1007/s00467-024-06389-3
Vancouver
Mencarelli F, Azukaitis K, Kirchner M, Bayazit A, Duzova A, Canpolat N, et al. Dyslipidemia in children with chronic kidney disease—findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study. Pediatric Nephrology. 2024;39(9):2759-2772. doi:10.1007/s00467-024-06389-3
BibTeX
@article{Mencarelli2024,
author = {Mencarelli, Francesca and Azukaitis, Karolis and Kirchner, Marietta and Bayazit, Aysun and Duzova, Ali and Canpolat, Nur and Bulut, Ipek Kaplan and Obrycki, Lukasz and Ranchin, Bruno and Shroff, Rukshana and Caliskan, Salim and Candan, Cengiz and Yilmaz, Alev and Özcakar, Zeynep Birsin and Halpay, Harika and Kiyak, Aysel and Erdogan, Hakan and Gellermann, Jutta and Balat, Ayse and Melk, Anette and Schaefer, Franz and Querfeld, Uwe},
title = {Dyslipidemia in children with chronic kidney disease—findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study},
journal = {Pediatric Nephrology},
year = {2024},
volume = {39},
number = {9},
pages = {2759--2772},
doi = {10.1007/s00467-024-06389-3}
}
EUVIMED